Full Name: GABA-A Receptor Associated Protein Like 2
Gene Symbol: GAIN (formerly GABARAPL2)
Gene ID: 124454
Chromosomal Location: 16p13.3
The GAIN gene encodes a protein belonging to the GABA-A receptor-associated protein (GABARAP) family. This family of proteins is primarily involved in autophagy, intracellular membrane trafficking, and receptor signaling. GAIN has been implicated in Parkinson's disease (PD) through genome-wide association studies (GWAS), making it a gene of interest in neurodegenerative disease research.
GAIN (GABARAPL2) plays a critical role in the autophagy-lysosome pathway, a cellular process responsible for degrading and recycling damaged organelles, protein aggregates, and other cellular components. Autophagy is particularly important in neurons due to their post-mitotic nature and high metabolic demands.
- Autophagosome Formation: GAIN is involved in the nucleation and expansion of autophagosomes, the double-membraned vesicles that engulf cellular debris for degradation
- Cargo Recognition: The protein helps recognize and package specific cargo into autophagosomes
- Fusion with Lysosomes: GAIN facilitates the fusion of autophagosomes with lysosomes to form autolysosomes
As suggested by its name, GAIN was initially identified as a protein interacting with GABA-A receptors:
- Receptor Trafficking: Facilitates the transport of GABA-A receptors to the cell membrane
- Receptor Clustering: Involved in clustering GABA-A receptors at synaptic sites
- Synaptic Inhibition: Supports proper GABAergic synaptic transmission
Multiple GWAS studies have identified single nucleotide polymorphisms (SNPs) in the GAIN genomic region as associated with Parkinson's disease risk:
- The GAIN locus on chromosome 16p13.3 represents a Parkinson's disease risk locus
- Risk alleles may affect gene expression or protein function
- The association suggests a role for autophagy dysfunction in PD pathogenesis
The connection between GAIN and Parkinson's disease likely involves:
- Alpha-Synuclein Clearance: Proper autophagy function is essential for clearing alpha-synuclein aggregates, a hallmark of PD
- Mitochondrial Quality Control: Autophagy is critical for removing damaged mitochondria (mitophagy), which is impaired in PD
- Neuronal Vulnerability: Dysregulated autophagy in neurons may contribute to cell death
GAIN is expressed in various tissues with high expression in:
- Brain (particularly in neurons)
- Heart
- Skeletal muscle
- Testis
In the brain, GAIN is expressed in multiple regions including the substantia nigra, cortex, and hippocampus—areas affected in Parkinson's and Alzheimer's diseases.
GAIN belongs to the GABARAP family which includes:
- GABARAP - GABA-A Receptor Associated Protein
- GABARAPL1 - GABARAP-like protein 1
- GABARAPL3 (also known as GAIN)
- GABARAPL4 - GABARAP-like protein 4
- GWAS-confirmed risk gene for sporadic Parkinson's disease
- May influence age of onset and disease progression
- Potential therapeutic target for modulating autophagy
Dysregulation of GAIN has been implicated in:
- Functional Studies: Understanding how GAIN variants affect autophagy function
- Therapeutic Targeting: Developing drugs that enhance GAIN-mediated autophagy
- Biomarkers: Exploring GAIN expression as a potential biomarker
- Gene Therapy: Investigating AAV-mediated GAIN delivery
- Alpha-Synuclein Protein that aggregates in PD
- LRRK2 - Common PD risk gene
- Parkin - Parkinson's disease gene involved in mitophagy
- Autophagy - Cellular degradation pathway
- Mechanisms of Parkinson's Disease